Jastrzębska M, Sankowski Z, Stanosz M. Anticoagulation effect of estroprogesterone therapy in women in menopausal period. Menopause Review/Przegląd Menopauzalny. 2005;4(1):48-52.
APA
Jastrzębska, M., Sankowski, Z., & Stanosz, M. (2005). Anticoagulation effect of estroprogesterone therapy in women in menopausal period. Menopause Review/Przegląd Menopauzalny, 4(1), 48-52.
Chicago
Jastrzębska, Maria, Zbigniew Sankowski, and Małgorzata Stanosz. 2005. "Anticoagulation effect of estroprogesterone therapy in women in menopausal period". Menopause Review/Przegląd Menopauzalny 4 (1): 48-52.
Harvard
Jastrzębska, M., Sankowski, Z., and Stanosz, M. (2005). Anticoagulation effect of estroprogesterone therapy in women in menopausal period. Menopause Review/Przegląd Menopauzalny, 4(1), pp.48-52.
MLA
Jastrzębska, Maria et al. "Anticoagulation effect of estroprogesterone therapy in women in menopausal period." Menopause Review/Przegląd Menopauzalny, vol. 4, no. 1, 2005, pp. 48-52.
Vancouver
Jastrzębska M, Sankowski Z, Stanosz M. Anticoagulation effect of estroprogesterone therapy in women in menopausal period. Menopause Review/Przegląd Menopauzalny. 2005;4(1):48-52.
Natural hormones enrolled in 35 women at estro-progesteronic therapy on coagulation system. The scientific work showed, that transdermal hormone therapy is not disturbing physiological balance in coagulation system.
Keywords
Fibrinogen, antithrombin III, thrombin-antithrombin complexes, and platelet factor